Severe eosinophilic asthma — SCE Respiratory MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Refer for anti-IL-5 biologic assessment
This is uncontrolled severe eosinophilic asthma and referral for biologic assessment such as anti-IL-5 treatment is the best next step. Omalizumab is targeted to allergic IgE-mediated asthma and is less appropriate without sensitisation. Macrolides and bronchial thermoplasty may have roles in selected patients, but type 2 biomarker-driven biologic assessment should precede maintenance oral steroid escalation.
Reference: BTS/NICE/SIGN Asthma Pathway 2024; ERS/ATS Severe Asthma Guideline